LAG3 and cancer: As of 27th February 2023, according to clinicaltrails.gov - there are 101 upcoming/ongoing clinical trials using anti-LAG3 either alone or in combination with other checkpoint inhibitors, targeted agents, or chemotherapeutic agents for various indications of cancer.